Brookstone Capital Management Acquires 3,663 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brookstone Capital Management raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,102 shares of the medical equipment provider’s stock after buying an additional 3,663 shares during the quarter. Brookstone Capital Management’s holdings in Intuitive Surgical were worth $9,448,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Mirador Capital Partners LP grew its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares during the last quarter. Exome Asset Management LLC lifted its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Intuitive Surgical by 73.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after buying an additional 114,149 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its position in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after buying an additional 76,649 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. BTIG Research upped their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup upped their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $539.75 on Tuesday. The business has a 50 day simple moving average of $536.58 and a 200 day simple moving average of $495.83. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $556.23. The stock has a market cap of $192.25 billion, a price-to-earnings ratio of 86.78, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.